Susquehanna International Group’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-78,800
Closed -$151K 12999
2024
Q3
$151K Sell
78,800
-124,700
-61% -$283K ﹤0.01% 10734
2024
Q2
$501K Buy
+203,500
New +$546K ﹤0.01% 8261
2023
Q2
Sell
-11,300
Closed -$128K 12908
2023
Q1
$128K Buy
+11,300
New +$120K ﹤0.01% 11072

Other funds holding PROK

Susquehanna International Group's PROK Position: Q1 2026 in Review

Susquehanna International Group reduced its ProKidney (PROK) stake by 49% in Q1 2026, selling an estimated $412K and leaving 204,488 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #10424.

Susquehanna International Group first reported a position in PROK in Q2 2023 and has held it in 9 quarters since. The position peaked at $893K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Susquehanna International Group held 204,488 shares of ProKidney worth $366K as of Q1 2026.
  • Susquehanna International Group sold 194,392 ProKidney shares in Q1 2026, an estimated $412K.
  • ProKidney made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10424 holding.
  • Susquehanna International Group first reported a position in ProKidney in Q2 2023 and has held it in 9 quarters since.
  • Susquehanna International Group's ProKidney position peaked at $893K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.